Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
| 4 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
| 12 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
| 26 | -0.79 | -16.934619507 | 4.665 | 6 | 3.15 | 556785 | 4.23223083 | CS |
| 52 | -4.9525 | -56.1030869442 | 8.8275 | 15.72 | 3.15 | 757615 | 5.75222812 | CS |
| 156 | -157.875 | -97.6043276662 | 161.75 | 227.7725 | 3.15 | 704603 | 16.8559698 | CS |
| 260 | -340.125 | -98.8735465116 | 344 | 359.75 | 3.15 | 549354 | 29.32782664 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
